G. Szabó

发表

Neoadjuvant immunotherapy of oral squamous cell carcinoma modulates intratumoral CD4/CD8 ratio and tumor microenvironment: a multicenter phase II clinical trial.

B. Döme, J. Tímár, É. Remenár, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.